Asia-pacific region making gains against HIV/AIDS, but more needs to be done, UNAIDS report says

NewsGuard 100/100 Score

Though the Asia-Pacific region "has seen impressive gains" in the fight against HIV/AIDS "-- including a 20 percent drop in new HIV infections since 2001 and a three-fold increase in access to antiretroviral therapy since 2006 -- progress is threatened by an inadequate focus on key populations at higher risk of HIV infection and insufficient funding from both domestic and international sources," according to a UNAIDS report (.pdf) released on Thursday at the 2011 International Congress on AIDS in Asia and the Pacific (ICAAP) in Busan, South Korea, a UNAIDS press release states (8/26).

Across the region, "the number of new HIV infections dropped from about 450,000 in 2001 to 360,000 in 2009," according to the report, Deutsche Presse-Agentur/M&C notes (8/26). "About 4.9 million people in the region had HIV in 2009, and that number has been relatively stable since 2005," the report states, Bloomberg News writes (Bennett, 8/26). According to the report, HIV/AIDS programs in the Asia-Pacific were under-funded, Xinhua reports. "In 2009, an estimated $1.1 billion was spent in AIDS/HIV programs in 30 countries across the region -- approximately one-third of the funding needed to achieve universal access goals to HIV services," according to the news agency (8/26).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New report on HIV drug resistance: Challenges and recommendations